APA (7th ed.) Citation

Pasi, K. J., Fischer, K., Ragni, M., Nolan, B., Perry, D. J., Kulkarni, R., . . . Mei, B. (2017). Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B. Thrombosis and haemostasis, 117(3), 508. https://doi.org/10.1160/TH16-05-0398

Chicago Style (17th ed.) Citation

Pasi, K John, et al. "Long-term Safety and Efficacy of Extended-interval Prophylaxis with Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Subjects with Haemophilia B." Thrombosis and Haemostasis 117, no. 3 (2017): 508. https://doi.org/10.1160/TH16-05-0398.

MLA (9th ed.) Citation

Pasi, K John, et al. "Long-term Safety and Efficacy of Extended-interval Prophylaxis with Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Subjects with Haemophilia B." Thrombosis and Haemostasis, vol. 117, no. 3, 2017, p. 508, https://doi.org/10.1160/TH16-05-0398.